Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison

Authors:

Abstract
No abstract available
Funding Information
  • Eli Lilly and Company

This publication has 17 references indexed in Scilit: